Document is current
Any future updates will be listed below
-
Authors
Harrod, Alison
Feng, Hugang
Ghaddar, Nagham
Schiavoni, Federica
Lane, Karen A.
Wu, Lillian
Zuazua-Villar, Pedro
Kozik, Zuzanna
Dobbs, Felix M.
van Eijk, Patrick
Koh, Gene Ching Chiek
Somaiah, Navita
Choudhary, Jyoti
Nik-Zainal, Serena
Reed, Simon H.
Downs, Jessica A.
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/W001276/1)
Kidani Foundation
Cancer Research UK (DRCRPG-Jun24/100004)
Sir Jeffrey Cheah Early Career Development Fellowship
National Institute for Health and Care Research (NIHR301627)
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
- License Information
-
More Information
Article History
Received: 17 October 2025
Accepted: 10 April 2026
First Online: 20 April 2026
Declarations
:
: Not applicable.
: Not applicable.
: The authors (PZV and JAD) hold a patent on the use of SWI/SNF deficiency as a biomarker for G4 ligand treatment (PCT/GB2024/051658). The authors declare no further competing interests.
